← Human Trials & Peer-Reviewed Studies

Effect of maternal supplement beverage with and without probiotics during pregnancy and lactation on maternal and infant health: a randomized controlled trial in the Philippines.

Plain-language guide to PMID 29855271 (2018): randomized controlled trial of Copper (Supplement).

Key Facts

PMID
29855271
Journal
BMC pregnancy and childbirth
Year
2018
Study type
Randomized Controlled Trial
Authors
Mantaring J et al. (7 authors)
DOI
10.1186/s12884-018-1828-8
Registered trial
NCT01073033

What This Study Did, in Plain Language

What Was Tested

Researchers studied Copper (Supplement) in this randomized controlled trial publication.

The primary objective of this study was to assess the effect of a maternal nutritional supplement enriched with probiotics during pregnancy and early lactation on the incidence of infant diarrhea.

Why It Was Studied

Adequate nutrition is essential during pregnancy and lactation to provide sufficient energy and nutrients to meet the nutritional requirements of the mother, fetus and infant.

Who Took Part

The age groups tagged for this paper are infants, young adults and adults, women only.

How the Study Was Run

The design is described as randomized.

The participants were allocated by chance, so the Copper (Supplement) group and the comparison group should start out alike.

Incidence of infant diarrhea until 12 months post-delivery was analyzed by Poisson regression.

The effect on maternal health, fetal growth, and infant growth and morbidity were also evaluated and analyzed by ANOVA.

What Was Measured

The subject headings attached to it are Beverages, Birth Weight, Breast Feeding, Diarrhea, Dietary Supplements, Fetal Development and Incidence.

The authors tagged it with the keywords Bifidobacterium lactis, Infant growth, Lactobacillus rhamnosus, Maternal supplementation, Probiotics and Safety.

What This Means in Plain Language

The paper is a randomized study of Copper (Supplement).

The abstract goes on to report its results in about 8 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2018 (BMC pregnancy and childbirth), a journal based in England.

More context: the Copper (Supplement) compound page, all human trials.

Our Notes on the Compound

Copper (Supplement): The active site of cytochrome c oxidase is described as containing copper ions that are essential for electron transfer.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.